Product Information

METOPROLOL SUCC ER 200 MG TAB is a generic product labeled by Oryza Pharmaceuticals Inc., priced at $0.1870 per EA under NDC 72516002801. Its NADAC has been published 33 times since Jan 7, 2026.

FDA first approved this application on Jul 26, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METOPROLOL SUCC ER 200 MG TAB

Metoprolol succinate
$0.1870per EA

Strength

200 mg/1

NDC

72516002801

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

METOPROLOL SUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA214110

FDA Approved

7/26/2024

TE Code

AB

On Market Since

7/21/2025

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for METOPROLOL SUCC ER 200 MG TAB has been published 33 times since Jan 7, 2026, and over the history we have for it it has declined 6.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1870 per EA
All-time high$0.1997 (Jan 14, 2026)
All-time low$0.1714 (Jun 17, 2026)
52-week high$0.1997
52-week low$0.1714
Median price$0.1820
Average price$0.1816
Largest weekly change+8.5% (Jul 22, 2026)
Weeks tracked33
Tracking sinceJan 7, 2026

Price History

1W

+0.6%

1M

+0.6%

3M

+7.8%

6M

+2.7%

1Y

N/A

3Y

N/A

5Y

N/A

All

-6.3%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METOPROLOL SUCC ER 200 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 200 MG TAB, manufactured by Oryza Pharmaceuticals Inc., is $0.1870 per EA (NDC 72516002801), effective Aug 19, 2026.

How has the price of METOPROLOL SUCC ER 200 MG TAB changed over time?

Over the history we have for it, the NADAC for METOPROLOL SUCC ER 200 MG TAB has declined 6.3%. It has been tracked across 33 weekly CMS publications since Jan 7, 2026.

What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 200 MG TAB?

Since Jan 7, 2026, the NADAC for METOPROLOL SUCC ER 200 MG TAB has ranged from a low of $0.1714 (Jun 17, 2026) to a high of $0.1997 (Jan 14, 2026), with a median of $0.1820 per EA.

Are there cheaper alternatives to METOPROLOL SUCC ER 200 MG TAB?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL SUCC ER 200 MG TAB, is $0.1734 per EA — about 7% below METOPROLOL SUCC ER 200 MG TAB.

Who manufactures METOPROLOL SUCC ER 200 MG TAB?

METOPROLOL SUCC ER 200 MG TAB (NDC 72516002801) is labeled by Oryza Pharmaceuticals Inc., and CMS classifies it as a generic product.